VocaMedi
HomeMedical DictionaryHermansky-Pudlak syndrome type 8
📢Advertisement[top]
ICD-10: E70.3genetic disorderGENETIC DISORDERSRARE DISEASES

Hermansky-Pudlak syndrome type 8

her-MAN-skee PUD-lak sin-drohm type eight

Also known as: HPS8, Hermansky-Pudlak syndrome 8

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

At a Glance

Type
genetic disorder
Age of Onset
early childhood
Inheritance
autosomal recessive
Prevalence
1 in 500,000

What is Hermansky-Pudlak syndrome type 8?

Hermansky-Pudlak syndrome type 8 is a rare genetic disorder that primarily affects the skin, eyes, and blood. It is caused by mutations in genes that are responsible for the formation and function of lysosome-related organelles. Over time, individuals with this condition may experience progressive lung disease and bleeding problems. Early symptoms often include albinism and visual impairment, while later symptoms can involve pulmonary fibrosis and colitis. Early diagnosis is crucial to manage symptoms and prevent complications. The condition can significantly impact family life due to the need for ongoing medical care and lifestyle adjustments. Prognosis varies depending on the severity of symptoms and the presence of complications. Daily life for affected individuals often involves regular medical check-ups, vision aids, and careful monitoring for bleeding and respiratory issues. Supportive therapies and interventions can improve quality of life. Genetic counseling is recommended for families to understand the inheritance pattern. Research is ongoing to better understand and treat this complex disorder.

Medical Definition

Hermansky-Pudlak syndrome type 8 is characterized by a defect in lysosome-related organelles due to mutations in the HPS8 gene. Pathologically, it involves oculocutaneous albinism, bleeding diathesis, and pulmonary fibrosis. Histological findings often reveal abnormal melanosomes and dense granules in platelets. It is classified under the Hermansky-Pudlak syndrome spectrum, which includes several subtypes with similar features. Epidemiologically, it is a rare disorder with a higher prevalence in certain populations. The disease course is progressive, with increasing severity of symptoms over time.

Hermansky-Pudlak syndrome type 8 Symptoms

Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.

Very Common

Oculocutaneous albinism

This symptom manifests as a lack of pigment in the skin, hair, and eyes, leading to light sensitivity and vision problems. The biological mechanism involves mutations affecting melanin synthesis. Over time, individuals may experience progressive vision impairment due to retinal and optic nerve involvement. Daily life is impacted by increased sunburn risk and vision challenges, necessitating protective clothing and visual aids.

Bleeding diathesis

Clinically, this presents as easy bruising, frequent nosebleeds, and prolonged bleeding from minor injuries. It is caused by platelet dysfunction due to defective dense granules. The bleeding tendency may worsen with age or remain stable, depending on individual factors. Patients must take precautions to avoid injuries and may require medical interventions like desmopressin or platelet transfusions during surgeries.

Pulmonary fibrosis

This symptom is characterized by progressive scarring of lung tissue, leading to shortness of breath and reduced exercise tolerance. The underlying mechanism involves abnormal fibroblast activity and inflammation in the lungs. Over time, lung function deteriorates, potentially leading to respiratory failure. Patients may require oxygen therapy and should avoid smoking and exposure to lung irritants.

Common

Colitis

Colitis manifests as abdominal pain, diarrhea, and sometimes rectal bleeding. It is caused by inflammation of the colon, possibly linked to immune dysregulation. Symptoms may fluctuate, with periods of remission and exacerbation. Management includes dietary modifications, anti-inflammatory medications, and monitoring for complications like anemia.

Neutropenia

Neutropenia presents as a reduced number of neutrophils, increasing infection risk. It results from bone marrow dysfunction or increased destruction of neutrophils. The condition may be chronic or episodic, with severity impacting infection susceptibility. Patients should practice good hygiene and may require antibiotics or growth factors during severe episodes.

Skin infections

These infections appear as recurrent or persistent skin lesions, often due to bacterial or fungal pathogens. The predisposition is linked to immune system abnormalities and skin barrier defects. Infections may become more frequent or severe over time without proper management. Treatment involves topical or systemic antimicrobials and maintaining skin hygiene.

Less Common

Granulomatous colitis

This rare form of colitis is characterized by granuloma formation in the colon, leading to abdominal pain and diarrhea. The exact cause is unclear but may involve immune system dysregulation. Symptoms can be chronic and may mimic other inflammatory bowel diseases. Management includes anti-inflammatory drugs and regular monitoring for complications.

Renal impairment

Renal impairment may manifest as reduced kidney function, leading to fluid retention and electrolyte imbalances. It is potentially linked to chronic inflammation or medication side effects. The condition can progress to chronic kidney disease if untreated. Regular monitoring of kidney function and lifestyle modifications are essential for management.

What Causes Hermansky-Pudlak syndrome type 8?

Hermansky-Pudlak syndrome type 8 is caused by mutations in the BLOC1S3 gene, located on chromosome 19q13. The BLOC1S3 gene encodes a protein that is part of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), which is crucial for the normal formation and function of lysosome-related organelles. Mutations in BLOC1S3 lead to structural changes in the BLOC-1 protein complex, impairing its ability to facilitate the trafficking of proteins to lysosome-related organelles. This disruption causes defects in the formation and function of organelles such as melanosomes, platelet dense granules, and lysosomes. Consequently, cells exhibit impaired pigmentation, bleeding disorders, and immune system dysfunction due to the failure of these organelles to perform their roles. The dysfunctional organelles lead to cellular stress and inflammation, triggering an immune response that exacerbates tissue damage. Neuroinflammation may result from the accumulation of dysfunctional organelles, contributing to neurodegeneration and cognitive symptoms. White matter degeneration occurs as a result of chronic inflammation and cellular stress, leading to the progressive neurological symptoms observed in patients. Symptoms appear in a specific pattern due to the varying reliance of different tissues on lysosome-related organelles, with highly dependent tissues being affected first. Disease severity varies between patients due to differences in the specific mutations, genetic background, and environmental factors that influence the extent of organelle dysfunction and immune response.

Genes Involved
BLOC1S3
📢Advertisement[mid-content]

How is Hermansky-Pudlak syndrome type 8 Diagnosed?

Typical age of diagnosis: Hermansky-Pudlak syndrome type 8 is typically diagnosed in early childhood when symptoms such as albinism, bleeding diathesis, and pulmonary complications become apparent. Diagnosis often follows a combination of clinical suspicion based on phenotype and confirmatory genetic testing. Early diagnosis is crucial for managing complications and improving quality of life. Family history and genetic counseling play significant roles in the diagnostic process.

1
Clinical Evaluation

Clinicians look for signs of oculocutaneous albinism, bleeding tendencies, and pulmonary symptoms. A detailed family history is important to identify any hereditary patterns. Physical examination may reveal hypopigmentation of the skin and hair, as well as signs of bleeding such as easy bruising or epistaxis. This step helps narrow down the differential diagnosis and guides further testing.

2
Imaging Studies

High-resolution CT scans of the chest are typically used to assess lung involvement. Specific abnormalities such as interstitial lung disease or pulmonary fibrosis may be visible. These findings can confirm the presence of pulmonary complications associated with the syndrome. Imaging helps exclude other causes of similar respiratory symptoms, such as infectious or other fibrotic diseases.

3
Laboratory Tests

Blood tests are ordered to evaluate platelet function and bleeding time. Biomarkers such as platelet aggregation studies may show abnormal results indicative of a bleeding disorder. Abnormal results guide the clinician towards considering Hermansky-Pudlak syndrome among other platelet function disorders. Laboratory tests are crucial in ruling out other hematological conditions.

4
Genetic Testing

Genetic testing involves sequencing genes known to be associated with Hermansky-Pudlak syndrome, such as HPS1 through HPS9. Mutations such as deletions or missense mutations are commonly found. Positive results confirm the diagnosis and provide a basis for genetic counseling. This information is vital for family planning and understanding the inheritance pattern.

Hermansky-Pudlak syndrome type 8 Treatment Options

⚠️ All treatment decisions should be made in consultation with a specialist experienced in this condition.
PharmacologicalAntifibrotic Agents

Antifibrotic agents such as pirfenidone or nintedanib are used to slow the progression of pulmonary fibrosis. These drugs work by inhibiting pathways that lead to fibrosis in lung tissue. Clinical trials have shown efficacy in reducing the decline in lung function over time. However, side effects such as gastrointestinal discomfort and liver enzyme abnormalities may limit their use. Regular monitoring of liver function tests is recommended during treatment.

Physical TherapyPulmonary Rehabilitation

Techniques include breathing exercises, aerobic conditioning, and strength training. The goal is to improve lung function and overall physical endurance. Sessions are typically conducted 2-3 times per week for several months. Measurable outcomes include improved exercise capacity and quality of life. Long-term benefits include reduced respiratory symptoms and enhanced daily functioning.

SurgicalLung Transplantation

Indicated for advanced pulmonary fibrosis with significant respiratory compromise. The procedure involves replacing diseased lungs with healthy donor lungs. Expected benefits include improved respiratory function and quality of life. Surgical risks include rejection, infection, and complications from immunosuppressive therapy. Post-operative care requires lifelong immunosuppression and regular follow-up.

Supportive CareMultidisciplinary Care Model

The team typically includes pulmonologists, hematologists, genetic counselors, and physical therapists. Interventions focus on managing symptoms, preventing complications, and providing psychosocial support. Strategies include regular follow-up, patient education, and family counseling. Family education emphasizes understanding the condition and its implications. Long-term monitoring involves regular assessments of lung function and bleeding risk.

When to See a Doctor for Hermansky-Pudlak syndrome type 8

🔴 Seek Emergency Care Immediately
  • Severe bleeding — this can indicate a critical bleeding disorder requiring immediate medical attention.
  • Shortness of breath — may signify pulmonary fibrosis or other serious lung complications.
  • Sudden vision loss — could indicate ocular complications that need urgent evaluation.
🟡 Contact Your Doctor Soon
  • Persistent cough — could be a sign of lung involvement and should be evaluated by a healthcare provider.
  • Frequent bruising — may indicate a bleeding tendency that requires further investigation.
  • Chronic diarrhea — could suggest gastrointestinal involvement and warrants medical assessment.
🟢 Monitor at Home
  • Mild fatigue — monitor energy levels and ensure adequate rest.
  • Occasional nosebleeds — track frequency and duration to discuss with a doctor if they worsen.

Hermansky-Pudlak syndrome type 8 — Frequently Asked Questions

Is this condition hereditary?

Hermansky-Pudlak syndrome type 8 is inherited in an autosomal recessive pattern. This means both parents must carry one copy of the mutated gene to pass it to their child. The probability of passing the condition to a child is 25% if both parents are carriers. De novo mutations are rare in this condition. Genetic counseling is recommended for affected families to understand carrier status and reproductive options.

What is the life expectancy for someone with this condition?

Life expectancy can vary depending on the severity of symptoms and age of onset. Pulmonary fibrosis and bleeding complications are major factors that can worsen outcomes. Mortality is often related to lung disease or bleeding events. Early diagnosis and management can improve survival and quality of life. Realistic expectations should include regular monitoring and treatment to manage symptoms.

How is this condition diagnosed and how long does diagnosis take?

Diagnosis involves a combination of clinical evaluation, genetic testing, and sometimes a biopsy. The time from first symptoms to diagnosis can vary, often taking months to years. Specialists such as geneticists, pulmonologists, and hematologists are typically involved. Delayed diagnosis is common due to symptom overlap with other conditions. Genetic testing confirms the diagnosis.

Are there any new treatments or clinical trials available?

Current research is exploring gene therapy and novel drug approaches to manage symptoms. ClinicalTrials.gov is a resource to find ongoing trials related to Hermansky-Pudlak syndrome. Patients should ask their doctors about eligibility for trials and potential benefits. New treatments are in development, but timelines for availability can vary. Staying informed about research developments is important.

How does this condition affect daily life and activities?

Mobility may be affected by fatigue and lung issues, impacting self-care. Educational adjustments may be needed due to vision or hearing impairments. Social and emotional challenges include coping with chronic illness and potential isolation. Family burden can be significant, requiring support and resources. Adaptations such as assistive devices and community support can greatly enhance quality of life.

Learn More

🔬 Spondylometaphyseal dysplasia, Schmidt type🔬 Klüver-Bucy syndrome🔬 Malformation syndrome with odontal and/or periodontal component🔬 Rare optic nerve disorder

Support & Resources

Hermansky-Pudlak Syndrome Network
The Hermansky-Pudlak Syndrome Network provides support and resources for individuals and families affected by the syndrome. They offer educational materials, advocacy, and opportunities to connect with others in the community. Membership is open to anyone interested in learning more or supporting their mission.
Global Genes
Global Genes is a leading rare disease advocacy organization. They provide resources, support, and connections for patients and families affected by rare conditions. Their website offers tools for finding support groups and learning about rare diseases.
🎓
Reviewed by a Health Management Academic
Öğr. Gör. Ahmet Bülbül ↗
Health Management · Health Psychology · Health Economics · Organizational Psychology
Academic since 2020 · Last reviewed: May 2026

References

Content generated with support from peer-reviewed literature via PubMed.

  1. 1.
    Hermansky-Pudlak Syndrome: Spectrum in Oman.

    Nazir HF, Al Sukaiti N, Khater D et al. · J Pediatr Hematol Oncol · 2023 · PMID: 36162005

  2. 2.
    Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1.

    Caro-Rivera LM, Malavez-Cajigas S, Lacourt-Ventura M et al. · Orphanet J Rare Dis · 2025 · PMID: 40355888

  3. 3.
    Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood.

    Hengst M, Naehrlich L, Mahavadi P et al. · Orphanet J Rare Dis · 2018 · PMID: 29580292

  4. 4.
    Dysregulated alveolar epithelial cell progenitor function and identity in Hermansky-Pudlak syndrome.

    Wang JY, Michki SN, Sitaraman S et al. · JCI Insight · 2024 · PMID: 39699958

  5. 5.
    Unusual colitides.

    Sanderson IR · Baillieres Clin Gastroenterol · 1994 · PMID: 8003742

  6. 6.
    The Hermansky-Pudlak syndrome.

    Brandt A, Offner F, Quatacker J et al. · Bull Soc Belge Ophtalmol · 1997 · PMID: 9745819

  7. 7.
    Emergence of inflammatory fibroblasts with aging in Hermansky-Pudlak syndrome associated pulmonary fibrosis.

    Banaschewski BJH, Michki SN, Sitaraman S et al. · Commun Biol · 2025 · PMID: 39987372

  8. 8.
    [Diagnosis of a case with Hermansky-Pudlak syndrome type 5 through high-throughput sequencing and a literature review].

    Wang D, Huang J, Zhang K et al. · Zhonghua Yi Xue Yi Chuan Xue Za Zhi · 2023 · PMID: 37906148

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-09